Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Jjr&D LLC currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action is being reviewed by 1 distinct examiner within 1 distinct art unit, representing a very focused point of prosecution for the company. This concentration indicates that the company's immediate patent efforts are directed toward a specific technical advancement rather than a broad portfolio of diverse applications.
RODRIGUEZ, RAYNA B is the busiest examiner, managing the 1 pending office action. This data indicates that the company's current interaction with the USPTO is limited to a single technical track. With only 1 distinct examiner and 1 distinct art unit involved, the administrative complexity is low, but the strategic importance of the 1 pending office action is high. The pending office action serves as the primary focus for the company's legal resources at this time.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RODRIGUEZ, RAYNA B | 1 | 33.6% | +19.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19180752 | Topical Benzimidazole Formulations and Methods for Use in Treating Inflammatory Dermatoses | RODRIGUEZ, RAYNA B | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19180752 | Topical Benzimidazole Formulations and Methods for Use in Treating Inflammatory Dermatoses | RODRIGUEZ, RAYNA B | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19180752 | Topical Benzimidazole Formulations and Methods for Use in Treating Inflammatory Dermatoses | RODRIGUEZ, RAYNA B | 1628 | §102§103Other | Final Rejection | — | Pending | Apr 16, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialJjr&D LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Rayna B Rodriguez has the most, with 1 of Jjr&D LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
